This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.
As Jones states in his foreword to this text, the introduction of ketoconazole therapy was an "epochal event in medical mycology." It began the age of orally administered azole treatment for fungal infections. In this book, much of what has been learned over the past eight years about ketoconazole and its clinical actions is reviewed in scholarly fashion and in a clear style, with good use of figures for data presentation. Also, the knowledge of pathophysiology that has been acquired from the use of ketoconazole is emphasized. The six chapters in the text cover the antimicrobial properties of ketoconazole, clinical experience with the drug in superficial fungal infections, systemic infections and subcutaneous mycoses, safety of ketoconazole therapy in clinical practice, and new areas of research interest. The literature on ketoconazole is completely reviewed and, in general, conservatively interpreted, primarily by Clissold, a New Zealander associated with ADIS Press, who wrote
Feingold D. Ketoconazole Today. Arch Dermatol. 1988;124(6):965–966. doi:10.1001/archderm.1988.01670060089030
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: